NAS
RDY icon

Nykredit A/S’s Dr. Reddy's Laboratories RDY Stock Holding History

Nykredit A/S’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Buy
+111,102
New +$1.5M 0.01% 606

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Nykredit A/S's RDY Position: Q2 2026 in Review

Nykredit A/S opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 111,102 shares worth $1.61M. The stake represents 0.01% of the portfolio and ranks #606 among its holdings.

238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Nykredit A/S held 111,102 shares of Dr. Reddy's Laboratories worth $1.61M as of Q2 2026.
  • Dr. Reddy's Laboratories was a new Nykredit A/S position in Q2 2026.
  • Dr. Reddy's Laboratories made up 0.01% of Nykredit A/S's portfolio in Q2 2026, its #606 holding.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.